THE USE OF PERSONALIZED BIOMARKERS FOR THE ASSESSMENT OF TUMOR RESPONSE AND DETERMINE FINAL MANAGEMENT IN RECTAL CANCER PATIENTS TREATED WITH NEOADJUVANT CHEMORADIATION

被引：0
|
作者：
Carpinetti, P.
Perez, R.
Habr-Gama, A.
Gama-Rodrigues, J.
Donnard, E.
Koyama, F.
Bettoni, F.
Parmigiani, R.
Galante, P.
Camargo, A.
机构：
来源：
DISEASES OF THE COLON & RECTUM | 2014年 / 57卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：E243 / E244
页数：2
相关论文
共 50 条
  • [41] Molecular Diagnosis of Response to Neoadjuvant Chemoradiation Therapy in Patients with Locally Advanced Rectal Cancer
    Chen, Zhenbin
    Duldulao, Marjun P.
    Li, Wenyan
    Lee, Wendy
    Kim, Joseph
    Garcia-Aguilar, Julio
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2011, 212 (06) : 1008 - U240
  • [42] Current views on clinical complete response in patients with rectal cancer following neoadjuvant chemoradiation
    Huerta, Sergio
    COLORECTAL CANCER, 2014, 3 (02) : 117 - 120
  • [43] Pathologic Response to Neoadjuvant Chemoradiation in Rectal Cancer Delineates Prognosis for Stage III Patients
    Karagkounis, Georgios
    Thai, Leo
    Mace, Adam G.
    Wiland, Homer
    Pai, Rish K.
    Church, James M.
    Kalady, Matthew F.
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2015, 221 (04) : S33 - S34
  • [44] Impact of neoadjuvant chemoradiation on pathologic response and survival of patients with locally advanced rectal cancer
    Conde, Sofia
    Borrego, Margarida
    Teixeira, Tania
    Teixeira, Rubina
    Corbal, Maria
    Sa, Anabela
    Soares, Paula
    REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPY, 2010, 15 (03) : 51 - 59
  • [45] Nodal Disease in Rectal Cancer Patients With Complete Tumor Response After Neoadjuvant Chemoradiation: Danger Below Calm Waters
    Baucom, Rebeccah B.
    Maguire, Lillias H.
    Kavalukas, Sandra L.
    Geiger, Timothy M.
    Ford, Molly M.
    Muldoon, Roberta L.
    Hopkins, M. Benjamin
    Hawkins, Alexander T.
    DISEASES OF THE COLON & RECTUM, 2017, 60 (12) : 1260 - 1266
  • [46] Cytokeratin 20 positive circulating tumor cells are a marker for response after neoadjuvant chemoradiation but not for prognosis in patients with rectal cancer
    Sebastian Hinz
    Christian Röder
    Jürgen Tepel
    Alexander Hendricks
    Clemens Schafmayer
    Thomas Becker
    Holger Kalthoff
    BMC Cancer, 15
  • [47] Sarcopenia is Associated with Inferior Response to Neoadjuvant Chemoradiation in Patients with Locally Advanced Rectal Cancer
    Wu, J. Y.
    Kuo, C. C.
    Ting, L. L.
    Kuo, L. J.
    Lee, H. L.
    Huang, Y.
    Cheng, C. J.
    Chiou, J. F.
    Lu, L. S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : E23 - E24
  • [48] Optimal Timing for Assessment of Tumor Response to Neoadjuvant Chemoradiation in Patients With Rectal Cancer: Do All Patients Benefit From Waiting Longer Than 6 Weeks?
    Perez, Rodrigo O.
    Habr-Gama, Angelita
    Sao Juliao, Guilherme P.
    Gama-Rodrigues, Joaquim
    Sousa, Afonso H. S., Jr.
    Campos, Fabio Guilherme
    Imperiale, Antonio R.
    Lynn, Patricio B.
    Proscurshim, Igor
    Nahas, Sergio Carlos
    Ono, Carla Rachel
    Buchpiguel, Carlos Alberto
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (05): : 1159 - 1165
  • [49] Metformin Use in Patients With Rectal Cancer Undergoing Neoadjuvant Chemoradiation: The New Magic Bullet?
    Perez, Rodrigo Oliva
    Fernandez, Laura M.
    Ortega, Cinthia D.
    DISEASES OF THE COLON & RECTUM, 2020, 63 (06) : 718 - 719
  • [50] Quality of life and circulating tumour cells in patients treated with neoadjuvant chemoradiation for rectal cancer - is there a link?
    Lim, S.
    Ng, W.
    Chua, W.
    Descallar, J.
    Spring, K.
    De Souza, P.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S224 - S224
12345